One Health Publications

U.S. Food and Drug Administration = Positive One Health impact... Strategic Plan for Regulatory Science Advancing Regulatory Science at FDA: A Strategic Plan (August 2011) The core responsibility of FDA is to protect consumers by applying the best possible science to its regulatory activities — from pre-market review of efficacy and safety to post-market product surveillance to review of product quality. FDA has developed a strategic plan for regulatory science, the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products. ...   See more:  http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/ucm267719.htm

Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) -  http://www.ceezad.org/   Review: Essay on History of One Medicine (One Health) “Medicine and Species: One Medicine, One History?”  contained within “The Oxford Handbook of History of Medicine”   Please see Publications:  http://www.ceezad.org/resources/publication.html via Attachment   By Robert E. Kahn, PhD Educational Consultant Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) Kansas State University Manhattan, Kansas (USA)

GRF One Health Summit 2012 One Health - One Planet - One Future Risks and Opportunities International Conference 19-23 February 2012, Davos, Switzerland   3rd Announcement - Programme & Exhibition Please see attachment and http://www.grforum.org/pages_new.php/One-Health/1013/1/938/  

A One Health Milestone...   U. S. Veterinary Journal Establishes Visionary One Health Policy and One Health Section   The official journal of the North American Veterinary Conference (NAVC), Clinician’s Brief http://www.cliniciansbrief.com/journal/october-2011: see View this Issue, a peer reviewed journal, has established a unique, visionary and seminal One Health policy...the journal is primarily designed to provide pertinent veterinary medical scientific articles for busy small animal medicine/surgery practitioners.  Clinician’s Brief has officially adopted support and advocacy of the One Health concept in its October 2011 issue.  In addition, a special One Health section will be published in each subsequent issue and posted on the One Health Initiative website.  The One Health section is entitled CAPSULES—Current literature in brief, featuring One Health Initiative Veterinary, Medical, Scientific [Highlights] —see page 39 in the current issue http://viewer.zmags.com/publication/54b87b67#/54b87b67/41.   The One Health Initiative team is delighted to have formed a collaborative liaison with NAVC’s Clinician’s Brief via its editor Indu Mani, DVM, DSc.  Please see attachments showing the  Front cover of the October 2011 Volume 9 Number 10 inaugural One Health issue: click on pdf view or http://www.onehealthinitiative.com/publications/cover2.pdf; the Contents Section: click on http://www.onehealthinitiative.com/publications/contents4.pdf; and Dr. Mani’s initial One Health Initiative Editorial commentary: click on http://www.onehealthinitiative.com/publications/indu4.pdf.    It should be noted that Dr. Mani, a veterinarian and avid One Health advocate, practices small animal veterinary medicine as well as being the editor of Clinician’s Brief.  She is also well versed in public health issues having received her Doctor of Science degree (DSc) from Harvard University’s School of Public Health in Boston, MA (USA).   The NAVC http://www.navc.com/ conducts a prominent and outstanding yearly meeting in Orlando, Florida (USA).  It is one of the largest veterinary medical continuing education events in the world.  A focus is maintained “on a single goal—providing high quality, practical information to every member of the veterinary [medical] professional team.”  The 2012 Conference is scheduled for January 14-18, 2012.

Health Council of the Netherlands Publish Advice on Antibiotic Use in Livestock Production and the Consequences for Human Public Health   August 31, 2011: http://www.gezondheidsraad.nl/en/publications/antibiotics-food-animal-production-and-resistant-bacteria-humans   Provided to One Health Initiative website October 11, 2011 by:   Dr. M.F.M. Langelaar Scientific staff member National Health Council of the Netherlands Parnassusplein 5 Postbus 16052 2500BB Den Haag Room C06 18 T 070-3406693 E mfm.langelaar@gr.nl

World Food Prize laureate to kick off new ISU One Health lecture series – October 12, 2011  “AMES, Iowa (USA)- The Iowa State University-based international organization One Health Commission will sponsor a lecture with ISU by 2010 World Food Prize Laureate David Beckmann at 9 a.m. Wednesday, Oct. 12, at the Des Moines Marriott, Salon D, at 700 Grand Ave. His presentation, One Health: World Health Through Collaboration, is scheduled in conjunction with this years World Food Prize events and is free and open to the public. ...” Please read more:  http://www.news.iastate.edu/news/2011/sep/onehealthlecture or click on HTM View.   Contacts: Roger Mahr, One Health Commission, 515-294-0572, rkmahr@onehealthcommission.org   Tracy Raef, College of Veterinary Medicine, 515-294-4602, traef@iastate.edu   Dan Kuester, News Service, 515-294-0704, kuester@iastate.edu

See important September 30, 2011 Huffington Post column (USA) that includes One Health implications:  ‘Contagion’ Connections: How Links Among Humans, Animals And The Environment May Be Spawning A New Class Of Infectious Diseases By Lynne Peeples lynne.peeples@huffingtonpost.com     Please SEE: http://www.huffingtonpost.com/2011/09/30/contagion-infectious-disease-animals-environment-health_n_987455.html?1317396819

Contagion Movie was One Health Deficient...making it Unrealistic!   What Contagion missed By Laura H. Kahn, MD, MPH, MPP | 29 September 2011 “Its not often that Hollywood ventures into the realm of epidemics and public health, and when it does, the outcome is usually laughably out of touch with reality -- like Outbreak, the 1995 movie about a deadly Ebola-like virus that infected a city. ...” Please read the entire review in Dr. Kahn’s Bulletin of the Atomic Scientists column:   http://thebulletin.org/web-edition/columnists/laura-h-kahn/what-contagion-missed  

Outstanding One Health-One Medicine Program at University of Missouri (USA)   To learn more, visit http://www.missouri.edu/mizzou-advantage/  or contact Facilitator Carolyn J. Henry, DVM, MS at henryc@missouri.edu   Dr. Henry is a veterinarian who concomitantly serves as Professor of Oncology at MU.  She also conducts biomedical cancer research that is of significant value to humans and animals.     http://facultycouncil.missouri.edu/meetings/documents/One-Health-one-page-1B9A50.pdf

One Health Newsletter Summer Issue Published today - September 26, 2011   A product of the Florida Department of Health, Environmental Health Division (USA)   http://www.doh.state.fl.us/Environment/medicine/One_Health/SummerOHNL2011-Combined.pdf

One Health Principles Needed for Ageing Research in Humans and Animals   http://www.izs.it/vet_italiana/2011/47_3/47_3.htm   “In these papers, I examine controversy over the nature of ageing.  Central ideas include why post-reproductive life span is relatively common among animals, and implications for evaluating.   Contentious debate revolves around whether ageing is a combined effect of life’s events on residuals of reproductive robustness, or whether ageing could be a purposeful product of natural selection.    In my view, complexities of ageing might be understood by simultaneously considering the cell, the organism, and the population.  The idea that events of post-reproductive life represent considerable investment of precious energy challenges some accepted precepts.   I suggest that ageing and its investments may have evolved at least partly as a means of niche preservation for populations and species at multiple levels of life.    It is clear that advancing knowledge and resolving questions and problems relative to ageing requires a One Health approach for human and animal species.  The necessary knowledge evolution will occur only by greatly increasing the level of interdisciplinary research, and especially direct collaborations between research scientists and health care providers across disciplines.”   Dennis F. Lawler, DVM Note: Dr. Lawler is a retired veterinarian currently residing in OFallon, Illinois (USA). He is a consultant in anatomic and clinical pathology for broad-scope genetics studies of the mammalian body plan, using the Portuguese Water Dog canine model, Project Georgie, the University of Utah, Salt Lake City (USA).  Permission for the One Health Initiative website to post access to these three articles was graciously granted on September 22, 2011 by Gill Dilmitis, Associate Editor, gsdilmitis@wanadoo.fr, Veterinaria Italiana Journal.

Poster presented in the 1st International Congress on Pathogens at the Human-Animal Interface(ICOPHAI), September 15-17, 2011: UN Conference Centre, Addis Ababa, Ethiopia.   Provided to One Health Initiative website September 23, 2011 by:   Professor Nitish C Debnath, DVM, MSc (TVM), PhDNational Consultant, Outbreak Response and Laboratory ExpertAvian Influenza Technical UnitFood and Agriculture Organization of the United NationsPshusampad Bhaban, Farmgate, Dhaka Bangladesh

Global Programs and Initiatives [One Health]   U.S. Department of Health and Human Services   http://www.globalhealth.gov/global-programs-and-initiatives/one-health/

National study on the prioritization of zoonotic diseases in the United States   September 19, 2011—The following message is being circulated on behalf of the Centre for Public Health and Zoonoses (CPHAZ) Research Team at the Ontario Veterinary College, University of Guelph, ON, Canada by the One Health Initiative Team. We encourage you to consider participation and strongly support the efforts of CPHAZ:   Please see attached PDF for more information...

Important New - September 2011 Catalog of One Health Activities and Programs (USA) Provided by: Will Hueston, DVM, PhD Executive Director, Global Initiative for Food Systems Leadership Professor, College of Veterinary Medicine and      Adjunct Professor, School of Public Health University of Minnesota St. Paul, MN (USA)  Tel:  612-625-5900 Fax: 612-624-4906  Email:  huest001@umn.edu Website:  www.foodsystemsleadership.org

Environmental levels of the antiviral Oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards   Josef D. Järhult 1, Shaman Muradrasoli 2, John Wahlgren 3, Hanna Söderström 4, Goran Orozovic 5, Gunnar Gunnarsson 5,6, Caroline Bröjer 7,8, Neus Latorre-Margalef5, Jerker Fick 4, Roman Grabic 4,9, Johan Lennerstrand 10, Jonas Waldenström 5, Åke Lundkvist 3, Björn Olsen 1,5   PLoS ONE, Monday 12 September 2011 – OPEN ACCESS   Abstract   “Oseltamivir (Tamiflu®) is the most widely used drug against influenza infections and is extensively stockpiled worldwide as part of pandemic preparedness plans. However, resistance is a growing problem and in 2008–2009, seasonal human influenza A/H1N1 virus strains in most parts of the world carried the mutation H274Y in the neuraminidase gene which causes resistance to the drug. The active metabolite of oseltamivir, oseltamivir carboxylate (OC), is poorly degraded in sewage treatment plants and surface water and has been detected in aquatic environments where the natural influenza reservoir, dabbling ducks, can be exposed to the substance. … “   Please read more http://www.plosone.org/article/infodoi10.1371journal.pone.0024742 or click on attachment.

FDA unveils foodborne illness outbreak response network  “Sep 14, 2011 (CIDRAP News) – The US Food and Drug Administration (FDA) announced today that it has established a new streamlined system to respond more efficiently and quickly to human and animal foodborne illness outbreaks.”  Please Read CIDRAP article...    http://www.cidrap.umn.edu/cidrap/content/fs/food-disease/news/sep1411network-br.html

Emerging Pathogens Institute (EPI) – University of Florida (USA) Foodsafety   Thursday, April 28, 2011     GAINESVILLE, Fla. (USA) – Researchers at the University of Florida Emerging Pathogens Institute have identified the Top 10 riskiest combinations of foods and disease-causing microorganisms, providing an important tool for food safety officials charged with protecting consumers from these costly and potentially life-threatening bugs.   Please see http://www.epi.ufl.edu/?q=RankingTheRisks or click on attachment

Important Essay on the History of One Medicine published in the United Kingdom (soon to be published in the USA): Contained within The Oxford Handbook of the History of Medicine   Medicine and Species: One Medicine, One History?               “University librarians may well be interested in The Oxford Handbook of the History of Medicine, already available in the United Kingdom and to be published in the United States on November 1st, 2011. Although expensive at $150, this innovative 672 page survey edited by Mark Jackson, contains an important essay by Robert G. W. Kirk and Michael Worboys, “Medicine and Species: One Medicine, One History?” which proposes “re-conceiving medicine as a set of knowledge-practices grounded in interspecies interactions.” In brief, the authors (a Wellcome Research Fellow and the Director of the Centre for the History of Science, Technology and Medicine at the University of Manchester) contend that the history of medicine “should become the history of one medicine” because of “the complex interactions between species that have been present throughout history”. ...”   Please read more by clicking on attached PDF   Book Review provided to One Health Initiative Website September 6, 2011 by:   Robert E. Kahn, PhD Educational Consultant Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) Kansas State University Manhattan, Kansas     

Progress towards the eradication of Tsetse from the Loos islands, Guinea   Moise S Kagbadouno1 , Mamadou Camara1 , Jérémy Bouyer2 , Fabrice Courtin3 , Mory F Onikoyamou 4 , Chris J Schofield5 and Philippe Solano3 1  Programme National de Lutte contre la THA, Ministère de la Santé, Conakry, Guinée 2  Cirad, UMR CIRAD-INRA CMAEE, ISRA-LNERV, Service de Parasitologie, Dakar-Hann, Sénégal 3  IRD, UMR IRD-CIRAD 177, CIRDES Bobo-Dioulasso BP 454, Burkina Faso 4  Direction de la Santé animale, Ministère de lélevage, Conakry, Guinée 5  LSHTM (ITD), London WC1E7HT, UK author email corresponding author email Parasites & Vectors 2011, 4:18doi:10.1186/1756-3305-4-18 – Published February 10, 2011 – Open Access The electronic version of this article is the complete one and can be found online at: http://www.parasitesandvectors.com/content/4/1/18       © 2011 Kagbadouno et al; licensee BioMed Central Ltd.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.   Abstract Background The tsetse fly Glossina palpalis gambiensis is the main vector of sleeping sickness (Human African Trypanosomiasis - HAT) in West Africa, in particular in littoral Guinea where this disease is currently very active. The Loos islands constitute a small archipelago some 5 km from mainland Guinea, where G. p. gambiensis is well known as a nuisance and potential disease vector by inhabitants of the three main islands, Fotoba, Room, and Kassa. The National Control Program against HAT of Guinea has decided to eradicate tsetse in Loos islands in order to sustainably protect humans and economic activities. After baseline data collection, tsetse control began on the islands in 2006. On each of the three islands a specific combination of control methods was implemented according to the entomological situation found. Results Starting densities before control operations were 10, 3 and 1 tsetse/trap/day in Kassa, Room and Fotoba respectively, but by July 2010, tsetse were no longer caught in any of the sentinel traps used for monitoring. The reduction rate was faster where several control methods were implemented as a combination (impregnated traps and targets ITT, selective groundspraying, epicutaneous insecticide treatment of pigs, and impregnated fences around pig pens), whereas it was slower when ITT were used as the only control method. Conclusions This 100% suppression is a promising step in the eradication process, but G. p. gambiensis may still occur at very low, undetectable, densities on the archipelago. Next step will consist in assessing a 0.05 probability of tsetse absence to ascertain a provisional eradication status. Throughout these operations, a key factor has been the involvement of local teams and local communities without whom such results would be impossible to obtain. Work will continue thanks to the partners involved until total eradication of the tsetse on Loos islands can be declared. Please read more: http://www.parasitesandvectors.com/content/4/1/18